Canopy Growth Corporation
General ticker "CGC" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $140.5M (TTM average)
Canopy Growth Corporation follows the US Stock Market performance with the rate: 10.0%.
Estimated limits based on current volatility of 3.4%: low 1.15$, high 1.23$
Factors to consider:
- Total employees count: 1029 (-36.5%) as of 2024
- US accounted for 13.8% of revenue in the fiscal year ended 2024-03-31
- Top business risk factors: Economic downturns and volatility, Management distraction, Litigation risks, Strategic risks and growth management, Integration challenges
- Current price 35.0% below estimated low
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-03-31 to 2026-03-31
- 2024-03-31 to 2025-03-31 estimated range: [2.68$, 7.28$]
- 2025-03-31 to 2026-03-31 estimated range: [1.86$, 5.33$]
Financial Metrics affecting the CGC estimates:
- Positive: with PPE of -1.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -34.66 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: 18.93 < Shareholder equity ratio, % of 38.48 <= 41.86
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 29.69 > -0.66
Short-term CGC quotes
Long-term CGC plot with estimates
Financial data
| YTD | 2022-03-31 | 2023-03-31 | 2024-03-31 |
|---|---|---|---|
| Operating Revenue | CA$475.70MM | CA$333.25MM | CA$297.15MM |
| Operating Expenses | CA$1,494.50MM | CA$2,963.77MM | CA$525.86MM |
| Operating Income | CA$-1,018.80MM | CA$-2,630.51MM | CA$-228.71MM |
| Non-Operating Income | CA$750.94MM | CA$-455.64MM | CA$-242.64MM |
| Interest Expense | CA$103.94MM | CA$126.16MM | CA$105.35MM |
| R&D Expense | CA$32.26MM | CA$21.72MM | CA$4.61MM |
| Income(Loss) | CA$-267.86MM | CA$-3,086.16MM | CA$-471.36MM |
| Taxes | CA$-8.95MM | CA$5.73MM | CA$12.33MM |
| Profit(Loss)* | CA$-310.04MM | CA$-3,278.16MM | CA$-657.27MM |
| Stockholders Equity | CA$3,589.96MM | CA$758.43MM | CA$500.37MM |
| Inventory | CA$204.54MM | CA$83.23MM | CA$77.29MM |
| Assets | CA$5,615.05MM | CA$2,439.70MM | CA$1,300.33MM |
| Operating Cash Flow | CA$-545.81MM | CA$-557.55MM | CA$-281.95MM |
| Capital expenditure | CA$48.11MM | CA$10.45MM | CA$4.00MM |
| Investing Cash Flow | CA$230.82MM | CA$433.38MM | CA$241.59MM |
| Financing Cash Flow | CA$-45.53MM | CA$-19.69MM | CA$-465.06MM |
| Earnings Per Share** | CA$-7.92 | CA$-70.69 | CA$-6.47 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.